000078 海王生物
按盤價 
2.350 +0.130 (+5.856%)
2.350 +0.130 (+5.856%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 8,087,938 | -18.78% | 36,418,770 | 37,834,859 | 41,053,584 | 40,022,495 | |
| 減：營業總成本 | 7,981,270 | -18.77% | 36,503,984 | 37,782,459 | 40,327,347 | 39,140,690 | |
| 其中:營業成本 | 7,245,190 | -18.53% | 32,865,445 | 34,045,035 | 36,655,494 | 35,375,256 | |
| 財務費用 | 179,369 | -0.88% | 943,621 | 905,212 | 807,226 | 890,299 | |
| 資產減值損失 | 956 | -63.27% | (962,355) | (550,406) | (197,520) | (587,009) | |
| 公允價值變動收益 | 116 | -- | 17,752 | 56,847 | 37,706 | 57,064 | |
| 投資收益 | (8,008) | -130.40% | (45,418) | (143,505) | 37,329 | 10,211 | |
| 其中：對聯營企業和合營企業的投資收益 | 52 | -97.75% | (26,996) | (106,917) | 46,675 | 54,635 | |
| 營業利潤 | 121,760 | -26.96% | (1,468,030) | (854,588) | 561,017 | 316,581 | |
| 利潤總額 | 121,638 | -28.13% | (1,458,474) | (853,160) | 576,310 | 267,443 | |
| 減：所得稅費用 | 52,467 | -11.08% | 260,559 | 138,290 | 318,443 | 308,731 | |
| 淨利潤 | 69,172 | -37.26% | (1,719,033) | (991,450) | 257,868 | (41,288) | |
| 減：非控股權益 | 26,530 | -25.73% | (29,088) | 35,519 | 164,572 | 247,243 | |
| 股東淨利潤 | 42,641 | -42.79% | (1,689,945) | (1,026,969) | 93,295 | (288,531) | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.016 | -40.22% | -0.642 | -0.391 | 0.036 | -0.110 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 1.107 | -35.96% | 1.092 | 1.705 | 2.117 | 2.137 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 31/05/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
